Any feedback?
Literature summary for 3.3.2.10 extracted from
- Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure (2014), Am. J. Physiol. Heart Circ. Physiol., 306, H1146-H1153.
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| trans-4-{4-[3-(4-trifluoromethoxyphenyl)-ureido]cyclohexyloxy}benzoic acid | - |
Mus musculus |  |
Localization
| Localization | Comment | Organism | GeneOntology No. | Textmining |
|---|---|---|---|---|
| soluble | - |
Mus musculus | - |
- |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Mus musculus | - |
- |
- |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| SEH | - |
Mus musculus |
General Information
| General Information | Comment | Organism |
|---|---|---|
| malfunction | the increased epoxyeicosatrienoic acid bioavailability, as a function of deficiency/inhibition of soluble epoxide hydrolase, potentiates vasodilator responses that counteract pressure-induced vasoconstriction to lower blood pressure | Mus musculus |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
